Whenever I think about the thesis for Pfizer Inc. ( PFE ), I can't help but ruminate over why the market has not shown much conviction despite PFE trading at valuations that are still undisputablyJR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and also by Seeking Alpha as a "Top Analyst To Follow" for Technology, Software, and Internet, as well as for Growth and GARP. I identify attractive risk/reward opportunities supported by robust price action to potentially gene ...

Wendy’s burger, fries and Frosty with the Wendy’s logo, evoking a deep-value stock turnaround rebound. Key Points Wendy's is well-positioned to rebound, but the timing is questionable amid competitors taking market share. Analysts are trimming targets but remain highly confident in the Hold rating.  Institutions and short-sellers have the market set up to be squeezed when a catalyst emerges. Interested in The Wendy's Company? Here are five stocks we like better. Wendy’s (NASDAQ: WEN) stock is down ...

Core Viewpoint - ASGN Inc has experienced significant selling pressure, resulting in a 15.4% decline in stock price over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) indicates that ASGN is currently in oversold territory with a reading of 29.21, suggesting a potential reversal in stock price [2][5] - RSI is a momentum oscillator that helps identify whether a stock is overbought or oversold, aiding investors in spotting entry opportunities for potential rebounds [3] Group 2: Fundamental Analysis - Analysts have raised earnings estimates for ASGN by 0.1% over the last 30 days, indicating a positive trend that typically correlates with price appreciation [7] - ASGN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which further supports the potential for a near-term turnaround [8]

Core Viewpoint - Cleveland-Cliffs' stock has experienced a significant decline, dropping 32.5% at its lowest point, primarily due to disappointing earnings and macroeconomic challenges, but there are signs of potential recovery in 2026 as market dynamics improve and steel prices rise [1][2][4]. Financial Performance - Cleveland-Cliffs reported a net loss of $1.4 billion for 2025, which is approximately double the loss from 2024 [6]. - The company ended a major five-year steel slab contract with ArcelorMittal USA in 2025 due to unprofitability stemming from a tariff-driven price gap [5]. Market Dynamics - The automotive sector, a key market for Cleveland-Cliffs, faced a slump in demand due to declining vehicle production in the U.S. during 2025 [4]. - However, management anticipates a recovery in automotive volumes and has already secured orders from clients, which is expected to positively impact revenue and earnings in 2026 [7]. Price Trends - Steel prices are expected to rise, with hot-rolled oil-steel prices projected to be nearly $60 per ton higher sequentially in the first quarter of 2026, with further improvements anticipated throughout the year [8]. - The Canadian subsidiary, Stelco, is expected to benefit from government-imposed restrictions on steel imports starting December 2025, which may enhance its market position [8]. Investment Outlook - Cleveland-Cliffs is viewed as a potential turnaround stock worth monitoring in 2026, given the anticipated recovery in market conditions and pricing [8].

Core Viewpoint - GrafTech International (EAF) has experienced a significant decline of 50.4% over the past four weeks, but it is now positioned for a potential trend reversal as it is in oversold territory, supported by analysts predicting better earnings than previously estimated [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a momentum oscillator that helps identify whether a stock is oversold, with readings below 30 indicating oversold conditions [2]. - EAF's current RSI reading is 23.28, suggesting that the heavy selling pressure may be exhausting itself, indicating a potential trend reversal [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts that earnings estimates for EAF have increased by 0.1% over the last 30 days, which typically correlates with price appreciation [7]. - EAF holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further indicating a potential turnaround [8].

分组1 - Analysts are divided on VF Corp (VFC) stock, with only three out of 22 rating it a Buy and a target price of $18.58, while the Barchart Technical Opinion suggests a Strong Buy for a more positive outlook [1] - VF Corp, known for brands like The North Face, Vans, and Timberland, is undergoing a turnaround involving divestitures and job cuts, with CEO Bracken Darrell leading the efforts since June 2023 [2] - VFC shares have increased by 13.3% year to date but have decreased by 75% over the past five years, indicating a significant long-term decline despite recent gains [2] 分组2 - The S&P 500 and Dow experienced losses of 1.23% and 1.20% respectively, while tech stocks also faced declines, highlighting a challenging market environment [6] - Pfizer's Q4 2025 results showed revenues of $17.56 billion, exceeding Wall Street's estimates, and earnings per share of $0.66, indicating a positive financial performance [15] - Pfizer's experimental weight-loss drug PF-08653944 is showing promising results in clinical trials, potentially positioning the company for recovery in the competitive pharmaceutical market [17]

Core Viewpoint - Genpact (G) has experienced a significant downtrend, with a 19.1% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a momentum oscillator that indicates whether a stock is oversold, with readings below 30 typically signaling this condition [2]. - Genpact's current RSI reading is 18.15, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound towards the previous equilibrium of supply and demand [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts regarding an increase in earnings estimates for Genpact, with a 0.1% rise in the consensus EPS estimate over the last 30 days, which often correlates with near-term price appreciation [7]. - Genpact holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a near-term turnaround [8].

While Nvidia’s (NVDA) price action is a case study for stocks going parabolic, the Jensen Huang-led company’s returns have been quite muted of late. Meanwhile, Intel (INTC), which was in the news not long ago for falling to multi-year lows, seems to have entered Nvidia’s orbit (sort of) and has been hitting multi-year highs. After gaining 84% in 2025, the stock was up over 22% year-to-date (YTD) as of Friday's closing prices. However, as typical after such rallies, Intel faced a reality check following t ...

Core Viewpoint - Nuvation Bio Inc. (NUVB) has experienced significant selling pressure, resulting in a 24.1% decline in stock price over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2] - NUVB's current RSI reading of 28.34 suggests that the heavy selling may be nearing exhaustion, indicating a potential for price recovery [5] Group 2: Fundamental Analysis - Analysts have raised earnings estimates for NUVB by 3.2% over the past 30 days, which often correlates with price appreciation [7] - NUVB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends, further supporting the potential for a turnaround [8]

Nike Inc (NYSE:NKE) stock rose Wednesday as investors weighed a notable insider purchase against ongoing concerns around tariffs, China demand, and a slower-than-expected turnaround.Tim Cook Steps Up Stake, Signaling ConfidenceNike stock extended its recent momentum after regulatory filings showed Apple Inc. (NASDAQ:AAPL) CEO Tim Cook increased his personal stake in the athletic apparel maker.A Monday filing revealed Cook bought 50,000 shares at an average price of $58.97, lifting his total holdings to 105, ...